Anti-inflammatory agent 54 exhibits anti-inflammatory activity by inhibiting the NF-κB pathway and downregulating the expression of iNOS, TNF-α, IL-6, and IL-1β; it suppresses LPS-induced nitric oxide (NO) production in RAW264.7 macrophages (IC50: 2.4 μM) and demonstrates in vivo anti-inflammatory efficacy in a mouse ear edema model.